SA
Sign upLog In

Biocryst Pharmaceuticals Inc (BCRX)

SG&A Expenses

$337.33M

TTM · Period ending: · USD

BCRX logo

BCRX SG&A Expenses

Latest reported$337.33M
BCRX TTM SG&A Expenses ($1.90M → $337.33M)
High-resolution chart · PNG

BCRX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
3,257,256
3,269,256
3,957,875
3,613,619
3,604,619
3,627,619
3,000,000
3,000,000
3,500,000
3,300,000
3,100,000
3,100,000
2,400,000
2,700,000
2,800,000
2,800,000
2,800,000
2,900,000
2,700,000
2,800,000
2,800,000
2,200,000
2,300,000
2,000,000
1,900,000
2,000,000
1,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.